Douglas C. Harnish

Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis

Songwen Zhang, Juan Wang, Qiangyuan Liu et al. · Journal of Hepatology · 2009 · 285 citations

Inflammation, Hepatology, Medicine +11

Reciprocal Antagonism Between Estrogen Receptor and NF-κB Activity In Vivo

Mark J. Evans, A Eckert, KehDih Lai et al. · Circulation Research · 2001 · 160 citations · Full text

The Role of CBP in Estrogen Receptor Cross-Talk with Nuclear Factor-κB in HepG2 Cells

Douglas C. Harnish, Marshall S. Scicchitano, Steven J. Adelman et al. · Endocrinology · 2000 · 141 citations

Inflammation, Signaling Pathway, Cell Regulation +18

Identification of pathway-selective estrogen receptor ligands that inhibit NF-κB transcriptional activity

Christopher C. Chadwick, Susan Chippari, Edward Matelan et al. · Proceedings of the National Academy of Sciences · 2005 · 135 citations · Full text

Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease

Douglas C. Harnish, Leo Albert, Yelena Leathurby et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2004 · 109 citations

Inflammation, Estrogen Receptors, Estrogen Treatment +15